Stocks
Boston Scientific (BSX) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1 833 | 2 784 | 2 800 | 3 620 | 3 620 | 4 091 | ||
| Changes by years, y/y, % | -12% | +52% | +1% | +29% | 0% | +8.4% | |||
Boston Scientific. EBITDA US GAAP, bln rub
Boston Scientific. EBITDA US GAAP, changes, %
Boston Scientific. EBITDA US GAAP, sum by quarters, bln rub
Boston Scientific (BSX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 801.0 | 1 016 | 1 016 | 1 001 | 1 058 | 4 091 | |
| Changes by years, y/y, % | +22% | +29% | +29% | +35% | +33% | |||
| Changes by quarters, q/q, % | +0% | +27% | 0% | -1% | +6% | |||
